Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of AngioX: Radial vs. Femoral | Clinical Trial - MATRIX: Radial vs. Femoral


The goal of the trial was to evaluate radial access compared with femoral access among subjects undergoing cardiac catheterization for acute coronary syndromes.

Contribution to the Literature: The MATRIX: Radial vs. Femoral trial showed that radial access for acute coronary syndromes was associated with reduced net adverse events compared with femoral access.